On Tuesday, January 7, shares of small cancer drug developer MAIA Biotechnology jumped more than 15% to hit their highest level in a month and a half as investors rushed to buy MAIA shares on news of the company’s new partnership with leading Chinese pharmaceutical firm BeiGene, positioning the duo…